Iowa City, IA, United States of America

Joseph Cullen


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Cullen: Innovator in Cancer Therapy

Introduction

Joseph Cullen is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on creating effective treatments for hyperproliferative disorders, showcasing his commitment to advancing medical science.

Latest Patents

Joseph Cullen holds a patent for "Compositions and methods for cancer therapy." This invention provides compositions and methods to treat a hyperproliferative disorder using ascorbate or a pharmaceutically acceptable salt thereof, along with at least one chelating agent that enhances ascorbate redox cycling (EDTA) to form HO, and one or more anti-cancer therapies. This patent highlights his dedication to finding new solutions in cancer treatment.

Career Highlights

Cullen is associated with the University of Iowa Research Foundation, where he continues to pursue his research interests. His work has the potential to impact the lives of many individuals suffering from cancer and related disorders. With 1 patent to his name, he is recognized for his innovative approach to medical challenges.

Collaborations

Joseph Cullen has collaborated with esteemed colleagues such as Bryan G Allen and Douglas R Spitz, Jr. These partnerships reflect his commitment to teamwork and the sharing of knowledge in the pursuit of scientific advancement.

Conclusion

Joseph Cullen's contributions to cancer therapy through his innovative patent demonstrate his dedication to improving healthcare. His work at the University of Iowa Research Foundation and collaborations with other professionals highlight the importance of innovation in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…